Arvinas, Inc.: Form 10-Q for the period ended Sep 30, 2024
Filed with the SEC on Oct 30, 2024 and accepted by EDGAR at Oct 30, 2024, 17:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-07-01 to 2024-09-30 | $102.4m | us-gaap:Revenues |
| Revenue | 9 months2024-01-01 to 2024-09-30 | $204.2m | us-gaap:Revenues |
| Research and development | 3 months2024-07-01 to 2024-09-30 | $86.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-01-01 to 2024-09-30 | $264.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-07-01 to 2024-09-30 | −$60.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-01-01 to 2024-09-30 | −$192.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-07-01 to 2024-09-30 | $0 | us-gaap:InterestExpense |
| Interest expense | 9 months2024-01-01 to 2024-09-30 | $0 | us-gaap:InterestExpense |
| Income tax | 3 months2024-07-01 to 2024-09-30 | $600.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-01-01 to 2024-09-30 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-07-01 to 2024-09-30 | −$49.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-01-01 to 2024-09-30 | −$153.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-07-01 to 2024-09-30 | −$0.68 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-01-01 to 2024-09-30 | −$2.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-07-01 to 2024-09-30 | −$0.68 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-01-01 to 2024-09-30 | −$2.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-07-01 to 2024-09-30 | 72,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-01-01 to 2024-09-30 | 71,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-01-01 to 2024-09-30 | −$175.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-01-01 to 2024-09-30 | $1.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-09-30 | $85.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-30 | $1.15bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-30 | $1.17bn | us-gaap:Assets |
| Current liabilities | At period end2024-09-30 | $275.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-09-30 | $581.1m | us-gaap:Liabilities |
| Long-term debt | At period end2024-09-30 | $600.0k | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-09-30 | $200.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-09-30 | $586.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001655759-24-000131. Last ingested by Listed: Nov 10, 2026, 04:49 ET. Listed shows no prices and gives no investment advice.